The Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome

• Status: Recruiting
• Trial end date: 2022-12-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to investigate the Psychiatric and Cognitive Phenotypes in Velocardiofacial Syndrome (VCFS), Williams Syndrome (WS)and Fragile X Syndrome Characterization, Treatment and Examining the Connection to Developmental and Molecular Factors

• Phase: Phase 4
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: The Chaim Sheba Medical Center
• Treatments: Methylphenidate; Risperidone

Criteria

Inclusion Criteria:

• chromosomal deletion proven by FISH examination

Exclusion Criteria: